Skip to main content
Clinical Trials/JPRN-UMIN000020326
JPRN-UMIN000020326
Recruiting
未知

Various visual functions and vision-related quality of life in patients with macular edema secondary to retinal vein occlusion following intravitreal ranibizumab injection. - Various visual functions and vision-related quality of life in patients with macular edema secondary to retinal vein occlusion following intravitreal ranibizumab injection.

niversity of Tsukuba0 sites46 target enrollmentMarch 8, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Macular edema secondary to retinal vein occlusion (RVO)
Sponsor
niversity of Tsukuba
Enrollment
46
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 8, 2016
End Date
December 31, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Tsukuba

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Previous history of vitreoretinal surgery 2\) Previous history of ophthalmic disorders except mild refractive errors and mild cataract 3\) Within 90 days of macular edema treatment \[ including sub\-Tenon triamcinolone acetonide (STTA), intravitreal bevacizumab (IVB), intravitreal ranibizumab (IVR), intravitreal aflibercept (IVA), topical steroid, carbonic anhydrase inhibitors (CAI) ] 4\) Within 90 days of intraocular surgery 5\) Contralateral eye of RVO 6\) Poor control of hypertension (HT) and diabetic mellitus (DM) 7\) Within 30 days of laser treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials